|
|
Prepublished online as a Blood First Edition Paper on July 5, 2002; DOI 10.1182/blood-2001-12-0207.

Submitted December 14, 2001
Accepted April 30, 2002
NOD/SCID/ cnull mouse: an excellent recipient mouse model for engraftment of human cells
Mamoru Ito*, Hidefumi Hiramatsu, Kimio Kobayashi, Kazutomo Suzue, Mariko Kawahata, Kyoji Hioki, Yoshito Ueyama, Yoshio Koyanagi, Kazuo Sugamura, Kohichiro Tsuji, Toshio Heike, and Tatsutoshi Nakahata
Central Institute for Experimental Animals, Kanagawa, Japan
Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan
Department of Parasitology, School of Medicine, Gunma University, Gunma, Japan
Department of Pathology, School of Medicine, Tokai University, Kanagawa, Japan
Department of Virology, Graduate School of Medicine, Tohoku University, Miyagi, Japan
Department of Immunology, Graduate School of Medicine, Tohoku University, Miyagi, Japan
Division of Cellular Therapy, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan
* Corresponding author; email: mito{at}ciea.or.jp.
To establish a more appropriate animal recipient for xenotransplantation, NOD/SCID/ cnull mice double homozygous for the severe combined immunodeficiency (SCID) mutation and IL-2R allelic mutation ( cnull) were generated by 8 back-cross matings of C57BL/6J- cnull mice and NOD/Shi-scid mice. When human CD34+ cells from umbilical cord blood were transplanted into this strain, the engraftment rate in the peripheral circulation, spleen, and bone marrow were significantly higher than that in NOD/Shi-scid mice treated with anti-asialo GM1 antibody or in the ß2-microglobulin deficient NOD/LtSz-scid (NOD/SCID/ß2m null) mice, which were as completely defective in NK cell activity as NOD/SCID/ cnull mice. The same high engraftment rate of human matured cells was observed in ascites when peripheral blood mononuclear cells were intraperitoneally transferred. In addition to the high engraftment rate, multi-lineage cell differentiation was also observed. Further, even 1 x 102 CD34+ cells could grow and differentiate in this strain. These results suggest that NOD/SCID/ cnull mice were superior animal recipients for xenotransplantation, and especially valuable for human stem cell assay. To elucidate the mechanisms involved in the superior engraftment rate in NOD/SCID/ cnull mice, cytokine production of spleen cells stimulated with Listeria monocytogenes antigens was compared among these three strains of mice. The IFN- production from dendritic cells from the NOD/SCID/ cnull mouse spleen was significantly suppressed in comparison with findings in 2 other strains of mice. It is suggested that multiple immunological dysfunctions, including cytokine production capability, in addition to functional incompetence of T, B and NK cells, may lead to the high engraftment levels of xenografts in NOD/SCID/ cnull mice.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. XuFeng, M. J. Boyer, H. Shen, Y. Li, H. Yu, Y. Gao, Q. Yang, Q. Wang, and T. Cheng
ADAR1 is required for hematopoietic progenitor cell survival via RNA editing
PNAS,
October 20, 2009;
106(42):
17763 - 17768.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kwant-Mitchell, A. A. Ashkar, and K. L. Rosenthal
Mucosal Innate and Adaptive Immune Responses against Herpes Simplex Virus Type 2 in a Humanized Mouse Model
J. Virol.,
October 15, 2009;
83(20):
10664 - 10676.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Kato, E. Fujii, Y. J. Chen, B. B Endaya, K. Matsubara, M. Suzuki, Y. Ohnishi, and N. Tamaoki
Spontaneous thymic lymphomas in the non-obese diabetic/Shi-scid, IL-2R{gamma}null mouse
Lab Anim,
October 1, 2009;
43(4):
402 - 404.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ito, T. Ishida, A. Utsunomiya, F. Sato, F. Mori, H. Yano, A. Inagaki, S. Suzuki, H. Takino, M. Ri, et al.
Defucosylated Anti-CCR4 Monoclonal Antibody Exerts Potent ADCC against Primary ATLL Cells Mediated by Autologous Human Immune Cells in NOD/Shi-scid, IL-2R{gamma}null Mice In Vivo
J. Immunol.,
October 1, 2009;
183(7):
4782 - 4791.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Plo, Y. Zhang, J.-P. Le Couedic, M. Nakatake, J.-M. Boulet, M. Itaya, S. O. Smith, N. Debili, S. N. Constantinescu, W. Vainchenker, et al.
An activating mutation in the CSF3R gene induces a hereditary chronic neutrophilia
J. Exp. Med.,
August 3, 2009;
206(8):
1701 - 1707.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Awong, E. Herer, C. D. Surh, J. E. Dick, R. N. La Motte-Mohs, and J. C. Zuniga-Pflucker
Characterization in vitro and engraftment potential in vivo of human progenitor T cells generated from hematopoietic stem cells
Blood,
July 30, 2009;
114(5):
972 - 982.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Brainard, E. Seung, N. Frahm, A. Cariappa, C. C. Bailey, W. K. Hart, H.-S. Shin, S. F. Brooks, H. L. Knight, Q. Eichbaum, et al.
Induction of Robust Cellular and Humoral Virus-Specific Adaptive Immune Responses in Human Immunodeficiency Virus-Infected Humanized BLT Mice
J. Virol.,
July 15, 2009;
83(14):
7305 - 7321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Watanabe, T. Takahashi, A. Okajima, M. Shiokawa, N. Ishii, I. Katano, R. Ito, M. Ito, M. Minegishi, N. Minegishi, et al.
The analysis of the functions of human B and T cells in humanized NOD/shi-scid/{gamma}cnull (NOG) mice (hu-HSC NOG mice)
Int. Immunol.,
July 1, 2009;
21(7):
843 - 858.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Abd-Elrahman, K. Hershko, T. Neuman, B. Nachmias, R. Perlman, and D. Ben-Yehuda
The Inhibitor of Apoptosis Protein Livin (ML-IAP) Plays a Dual Role in Tumorigenicity
Cancer Res.,
July 1, 2009;
69(13):
5475 - 5480.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Bohana-Kashtan, S. Morisot, R. Hildreth, C. Brayton, H. I. Levitsky, and C. I. Civin
Selective Reduction of Graft-versus-Host Disease-Mediating Human T Cells by Ex Vivo Treatment with Soluble Fas Ligand
J. Immunol.,
July 1, 2009;
183(1):
696 - 705.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. M. Carreno, J. R. Garbow, G. R. Kolar, E. N. Jackson, J. A. Engelbach, M. Becker-Hapak, L. N. Carayannopoulos, D. Piwnica-Worms, and G. P. Linette
Immunodeficient Mouse Strains Display Marked Variability in Growth of Human Melanoma Lung Metastases
Clin. Cancer Res.,
May 15, 2009;
15(10):
3277 - 3286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kai, T. Hagiwara, C. Emuta, Y. Chisaka, K. Tsuruhata, C. Endo, Y. Inagaki, H. Miyazaki, and S. Kataoka
In vivo efficacy of anti-MPL agonist antibody in promoting primary human hematopoietic cells
Blood,
March 5, 2009;
113(10):
2213 - 2216.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Z. Dewan, N. Takamatsu, T. Hidaka, K. Hatakeyama, S. Nakahata, J.-i. Fujisawa, H. Katano, N. Yamamoto, and K. Morishita
Critical Role for TSLC1 Expression in the Growth and Organ Infiltration of Adult T-Cell Leukemia Cells In Vivo
J. Virol.,
December 1, 2008;
82(23):
11958 - 11963.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Arnold, B. Zimmerman, M. Li, M. D. Lairmore, and P. L. Green
Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation
Blood,
November 1, 2008;
112(9):
3788 - 3797.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Nogami, H. Yoshida, K. Koizumi, H. Yamada, K. Abe, A. Arimura, N. Yamane, K. Takahashi, A. Yamane, A. Oda, et al.
The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis
Haematologica,
October 1, 2008;
93(10):
1495 - 1504.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Nguyen and T. Xu
The expanding role of mouse genetics for understanding human biology and disease
Dis. Model. Mech.,
July 1, 2008;
1(1):
56 - 66.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Simpson-Abelson, G. F. Sonnenberg, H. Takita, S. J. Yokota, T. F. Conway Jr., R. J. Kelleher Jr., L. D. Shultz, M. Barcos, and R. B. Bankert
Long-Term Engraftment and Expansion of Tumor-Derived Memory T Cells Following the Implantation of Non-Disrupted Pieces of Human Lung Tumor into NOD-scid IL2R{gamma}null Mice
J. Immunol.,
May 15, 2008;
180(10):
7009 - 7018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Watanabe, S. Ohta, M. Yajima, K. Terashima, M. Ito, H. Mugishima, S. Fujiwara, K. Shimizu, M. Honda, N. Shimizu, et al.
Humanized NOD/SCID/IL2R{gamma}null Mice Transplanted with Hematopoietic Stem Cells under Nonmyeloablative Conditions Show Prolonged Life Spans and Allow Detailed Analysis of Human Immunodeficiency Virus Type 1 Pathogenesis
J. Virol.,
December 1, 2007;
81(23):
13259 - 13264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ono, T. Maruyama, H. Masuda, T. Kajitani, T. Nagashima, T. Arase, M. Ito, K. Ohta, H. Uchida, H. Asada, et al.
Side population in human uterine myometrium displays phenotypic and functional characteristics of myometrial stem cells
PNAS,
November 20, 2007;
104(47):
18700 - 18705.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Fujino, H. Hiramatsu, A. Tsuchiya, A. Niwa, H. Noma, M. Shiota, K. Umeda, M. Yoshimoto, M. Ito, T. Heike, et al.
Human cord blood CD34+ cells develop into hepatocytes in the livers of NOD/SCID/{gamma}cnull mice through cell fusion
FASEB J,
November 1, 2007;
21(13):
3499 - 3510.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-L. Sellier-Leclerc, A. Duval, S. Riveron, M.-A. Macher, G. Deschenes, C. Loirat, M.-C. Verpont, M. Peuchmaur, P. Ronco, R. C. Monteiro, et al.
A Humanized Mouse Model of Idiopathic Nephrotic Syndrome Suggests a Pathogenic Role for Immature Cells
J. Am. Soc. Nephrol.,
October 1, 2007;
18(10):
2732 - 2739.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Christ, K. Lucke, S. Imren, K. Leung, M. Hamilton, A. Eaves, C. Smith, and C. Eaves
Improved purification of hematopoietic stem cells based on their elevated aldehyde dehydrogenase activity
Haematologica,
September 1, 2007;
92(9):
1165 - 1172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kawase, Y. Akatsuka, H. Torikai, S. Morishima, A. Oka, A. Tsujimura, M. Miyazaki, K. Tsujimura, K. Miyamura, S. Ogawa, et al.
Alternative splicing due to an intronic SNP in HMSD generates a novel minor histocompatibility antigen
Blood,
August 1, 2007;
110(3):
1055 - 1063.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Gorantla, H. Sneller, L. Walters, J. G. Sharp, S. J. Pirruccello, J. T. West, C. Wood, S. Dewhurst, H. E. Gendelman, and L. Poluektova
Human Immunodeficiency Virus Type 1 Pathobiology Studied in Humanized BALB/c-Rag2-/-{gamma}c-/- Mice
J. Virol.,
March 15, 2007;
81(6):
2700 - 2712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Fujii, J. D. Trudeau, D. T. Teachey, J. D. Fish, S. A. Grupp, K. R. Schultz, and G. S. D. Reid
In vivo control of acute lymphoblastic leukemia by immunostimulatory CpG oligonucleotides
Blood,
March 1, 2007;
109(5):
2008 - 2013.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Masuda, T. Maruyama, E. Hiratsu, J. Yamane, A. Iwanami, T. Nagashima, M. Ono, H. Miyoshi, H. J. Okano, M. Ito, et al.
Noninvasive and real-time assessment of reconstructed functional human endometrium in NOD/SCID/{gamma}Formula immunodeficient mice
PNAS,
February 6, 2007;
104(6):
1925 - 1930.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Watanabe, K. Terashima, S. Ohta, S. Horibata, M. Yajima, Y. Shiozawa, M. Z. Dewan, Z. Yu, M. Ito, T. Morio, et al.
Hematopoietic stem cell-engrafted NOD/SCID/IL2R{gamma}null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses
Blood,
January 1, 2007;
109(1):
212 - 218.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Miyazato, J.-i. Yasunaga, Y. Taniguchi, Y. Koyanagi, H. Mitsuya, and M. Matsuoka
De Novo Human T-Cell Leukemia Virus Type 1 Infection of Human Lymphocytes in NOD-SCID, Common {gamma}-Chain Knockout Mice
J. Virol.,
November 1, 2006;
80(21):
10683 - 10691.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Yahata, S. Yumino, Y. Seng, H. Miyatake, T. Uno, Y. Muguruma, M. Ito, H. Miyoshi, S. Kato, T. Hotta, et al.
Clonal analysis of thymus-repopulating cells presents direct evidence for self-renewal division of human hematopoietic stem cells
Blood,
October 1, 2006;
108(7):
2446 - 2454.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Nakamura, Y. Miyakawa, A. Miyamura, A. Yamane, H. Suzuki, M. Ito, Y. Ohnishi, N. Ishiwata, Y. Ikeda, and N. Tsuruzoe
A novel nonpeptidyl human c-Mpl activator stimulates human megakaryopoiesis and thrombopoiesis
Blood,
June 1, 2006;
107(11):
4300 - 4307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Muguruma, T. Yahata, H. Miyatake, T. Sato, T. Uno, J. Itoh, S. Kato, M. Ito, T. Hotta, and K. Ando
Reconstitution of the functional human hematopoietic microenvironment derived from human mesenchymal stem cells in the murine bone marrow compartment
Blood,
March 1, 2006;
107(5):
1878 - 1887.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Legrand, K. Weijer, and H. Spits
Experimental Models to Study Development and Function of the Human Immune System In Vivo
J. Immunol.,
February 15, 2006;
176(4):
2053 - 2058.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Ishikawa, M. Yasukawa, B. Lyons, S. Yoshida, T. Miyamoto, G. Yoshimoto, T. Watanabe, K. Akashi, L. D. Shultz, and M. Harada
Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chainnull mice
Blood,
September 1, 2005;
106(5):
1565 - 1573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Matsuura-Sawada, T. Murakami, Y. Ozawa, H. Nabeshima, J.-i. Akahira, Y. Sato, Y. Koyanagi, M. Ito, Y. Terada, and K. Okamura
Reproduction of menstrual changes in transplanted human endometrial tissue in immunodeficient mice
Hum. Reprod.,
June 1, 2005;
20(6):
1477 - 1484.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. D. Shultz, B. L. Lyons, L. M. Burzenski, B. Gott, X. Chen, S. Chaleff, M. Kotb, S. D. Gillies, M. King, J. Mangada, et al.
Human Lymphoid and Myeloid Cell Development in NOD/LtSz-scid IL2R{gamma}null Mice Engrafted with Mobilized Human Hemopoietic Stem Cells
J. Immunol.,
May 15, 2005;
174(10):
6477 - 6489.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Nakata, K. Maeda, T. Miyakawa, S. Shibayama, M. Matsuo, Y. Takaoka, M. Ito, Y. Koyanagi, and H. Mitsuya
Potent Anti-R5 Human Immunodeficiency Virus Type 1 Effects of a CCR5 Antagonist, AK602/ONO4128/GW873140, in a Novel Human Peripheral Blood Mononuclear Cell Nonobese Diabetic-SCID, Interleukin-2 Receptor {gamma}-Chain-Knocked-Out AIDS Mouse Model
J. Virol.,
February 15, 2005;
79(4):
2087 - 2096.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. N. La Motte-Mohs, E. Herer, and J. C. Zuniga-Pflucker
Induction of T-cell development from human cord blood hematopoietic stem cells by Delta-like 1 in vitro
Blood,
February 15, 2005;
105(4):
1431 - 1439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Traggiai, L. Chicha, L. Mazzucchelli, L. Bronz, J.-C. Piffaretti, A. Lanzavecchia, and M. G. Manz
Development of a Human Adaptive Immune System in Cord Blood Cell-Transplanted Mice
Science,
April 2, 2004;
304(5667):
104 - 107.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kambe, H. Hiramatsu, M. Shimonaka, H. Fujino, R. Nishikomori, T. Heike, M. Ito, K. Kobayashi, Y. Ueyama, N. Matsuyoshi, et al.
Development of both human connective tissue-type and mucosal-type mast cells in mice from hematopoietic stem cells with identical distribution pattern to human body
Blood,
February 1, 2004;
103(3):
860 - 867.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Palucka, J. Gatlin, J. P. Blanck, M. W. Melkus, S. Clayton, H. Ueno, E. T. Kraus, P. Cravens, L. Bennett, A. Padgett-Thomas, et al.
Human dendritic cell subsets in NOD/SCID mice engrafted with CD34+ hematopoietic progenitors
Blood,
November 1, 2003;
102(9):
3302 - 3310.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Yoshida, R. Tanaka, T. Murakami, Y. Takahashi, Y. Koyanagi, M. Nakamura, M. Ito, N. Yamamoto, and Y. Tanaka
Induction of Protective Immune Responses against R5 Human Immunodeficiency Virus Type 1 (HIV-1) Infection in hu-PBL-SCID Mice by Intrasplenic Immunization with HIV-1-Pulsed Dendritic Cells: Possible Involvement of a Novel Factor of Human CD4+ T-Cell Origin
J. Virol.,
August 15, 2003;
77(16):
8719 - 8728.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hiramatsu, R. Nishikomori, T. Heike, M. Ito, K. Kobayashi, K. Katamura, and T. Nakahata
Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD/SCID/{gamma}cnull mice model
Blood,
August 1, 2003;
102(3):
873 - 880.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Z. Dewan, K. Terashima, M. Taruishi, H. Hasegawa, M. Ito, Y. Tanaka, N. Mori, T. Sata, Y. Koyanagi, M. Maeda, et al.
Rapid Tumor Formation of Human T-Cell Leukemia Virus Type 1-Infected Cell Lines in Novel NOD-SCID/{gamma}cnull Mice: Suppression by an Inhibitor against NF-{kappa}B
J. Virol.,
May 1, 2003;
77(9):
5286 - 5294.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Marodon, E. Mouly, E. J. Blair, C. Frisen, F. M. Lemoine, and D. Klatzmann
Specific transgene expression in human and mouse CD4+ cells using lentiviral vectors with regulatory sequences from the CD4 gene
Blood,
May 1, 2003;
101(9):
3416 - 3423.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|